An extensive literature14 implicates tumor-cell-extrinsic innate and/or adaptive resistance factors involving various immune cell types (e.g., regulatory T cells and M2 macrophages) and immune checkpoints distinct from PD-1 and CTLA-4. This evidence concerns the gene CTLA4 and neoplasm.